Diagnostics channel feed

El­e­ment Bio­sciences logs 100 DNA se­quencer or­ders as it gains mo­men­tum in a com­pet­i­tive mar­ket

2 weeks ago

Il­lu­mi­na be­gan hunt for CEO can­di­dates in midst of ac­tivist fight, even­tu­al­ly pick­ing lit­tle-known di­ag­nos­tics ex­ec

3 weeks ago
People

Il­lu­mi­na names for­mer Ag­i­lent ex­ec as CEO, months af­ter part­ing ways with deS­ouza

3 weeks ago
People

PacBio, once slat­ed to be ac­quired by Il­lu­mi­na, is tak­ing on the DNA gi­ant

4 weeks ago
In Focus

His tiny pre­na­tal test­ing com­pa­ny has big plans af­ter ex­act­ing le­gal re­venge on lab gi­ants

Last month
R&D
In Focus

Di­ag­nos­tics out­fit lays off third of em­ploy­ees, now look­ing at 's­trate­gic al­ter­na­tives'

4 months ago
People

FDA warns some Il­lu­mi­na DNA se­quenc­ing de­vices could be vul­ner­a­ble to hack­ers

4 months ago
FDA+

Quest Di­ag­nos­tics buys Bert Vo­gel­stein’s Haystack On­col­o­gy, just six months af­ter Se­ries A

4 months ago
Deals

Pat­tern Bio­science rais­es $28.7M Se­ries C for faster, more ef­fi­cient an­tibi­ot­ic re­sis­tance test

4 months ago
Financing

As show­down with ac­tivist nears, Il­lu­mi­na’s CEO de­fends the com­pa­ny’s $7.1B pur­chase of Grail

4 months ago
Deals

Ex-US Com­merce Sec­re­tary Wilbur Ross pairs his SPAC with Alzheimer's biotech

8 months ago
Startups
Deals

Qi­a­gen picks up DNA foren­sics com­pa­ny for $150M

8 months ago
Deals

Ther­mo Fish­er wa­gers on ear­ly can­cer di­ag­nos­tics in $2.6B cash deal for mul­ti­ple myelo­ma test mak­er

10 months ago
Deals

Af­ter block­ing Grail ac­qui­si­tion, EU leaves Il­lu­mi­na with few good op­tions

Last year
Deals

Chi­na's DNA gi­ant con­fronts skep­ti­cism in US ex­pan­sion bid

Last year
China
In Focus

Ko­re­an di­ag­nos­tics biotech goes transpa­cif­ic, agree­ing to shell out $1.5B to take Merid­i­an pri­vate

Last year
Deals

As new mon­key­pox cas­es spike glob­al­ly, Lab­corp rolls out first na­tion­al lab test

Last year
Pharma

Roche's ROS1+ can­cer drug gets FDA green­light for Foun­da­tion Med­i­cine's com­pan­ion di­ag­nos­tic

Last year
Pharma

Pre­ci­sion drug + di­ag­nos­tics biotech scores mod­est Se­ries A, retro­fitting ex­ist­ing drug for new in­di­ca­tion

Last year
Financing

Bay Area ge­nomics start­up emerges from stealth with $600M in the bank and promis­ing a '$100 genome' test

Last year
Startups

Guardant Health fires back at Il­lu­mi­na suit, claim­ing re­tal­i­a­tion over its role in FTC an­titrust in­ves­ti­ga­tion

Last year
Law

Roche un­veils three new mon­key­pox tests as cas­es rise

Last year
Pharma

Can On­co­Host's PROphet pre­dict host re­sponse to can­cer treat­ments? In­vestors are wait­ing to find out

Last year
Financing

Wait, what? Or­a­cle tech founder Lar­ry El­li­son in­vests in­to ex-stealth ge­nomics di­ag­nos­tics biotech

Last year
AI
12 Next page Last page
A service from the Financial Times